August 2018 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Readying Sanofi For The Era Of Digital Health
- Fibrocell: Where Gene Therapy Meets Synthetic Biology
- Alexis Howerton On Starting Up From New Science
- How To Broker Strategic Alliances Between International Biopharma Stakeholders
Capitol Perspectives
Patient Perspectives
CEO Corner
From Principles and Policy to Execution
Industry Research
Companies To Watch
Inside The Industry
- Biopharma Startups Seek Big Pharma Expertise
- Mitigating Risks In Countries With Poor IP Protection
- Samsung Bioepis: Applying The “Hunger” For Biosimilars To Novel Drugs
- French Bioclusters Refocus Collaboration Efforts
Leadership Lessons
Industry Leader
- As Pediatric Rare Disease Patients Grow Up, Can We Keep Pace?
- Why Soft Skills Are The Key To Better Science And Collaborations
Ask The Board
- When Do You Think BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In Clinical Research?
- What Are Pharma Companies Doing To Provide Greater Commitment To Ethical Practices And Transparencies Along With Corporate Social Responsibility?
- What Are The Socioeconomic Impacts Of Life-Span-Extending Medicines And Treatments? What Developments Are Really Promising?
This website uses cookies to ensure you get the best experience on our website. Learn more